홈 > 시장보고서 > 의약품

시장보고서

상품코드

1280677

세계의 바이오프리저베이션(Biopreservation) 시장 규모, 시장 점유율, 용도 분석, 지역별 전망, 성장 동향, 주요 기업, 경쟁 전략 및 예측(2023-2031년)

Biopreservation Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

발행일: 2023년 05월 | 리서치사:

Acute Market Reports | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오프리저베이션 시장은 2031년까지 9.5%를 나타낼 것으로 예상됩니다. 식품 재료의 보존 기간을 연장하기 위해 천연 또는 통제된 항균제를 적용하는 과정을 생물학적 보존존으로 알려져 있습니다. 생물 보존존의 과정은 일반적으로 유산균(LAB)의 도움을 받아 이루어지며, LAB는 식품의 부패를 유발하는 미생물을 억제하기 때문입니다. 생물 보존존 과정에서 적용되는 주요 약물은 유산균, 효모, 박테리오파지입니다. 육류, 어패류 등의 식재료를 보존하기 위해 진행되는 과정입니다. 바이오프리저베이션 시장은 제품, 애플리케이션, 세포 공급자로 분류할 수 있습니다. 바이오프리저베이션 존 시장의 제품 카테고리는 미디어, 장비, 실험실 정보 관리 시스템으로 분류됩니다. 장비류는 냉동고, 냉장고, 액체질소 탱크, 소모품으로, 배지는 조제 배지와 자가 제조 배지로 세분화됩니다. 바이오프리저베이션 프로세스의 주요 용도는 바이오뱅크, 재생의료, 신약개발입니다. 주요 세포 공급자는 CD19, 종양세포, CD34, iPSC, MSC, hESC로 나뉩니다.

바이오프리저베이션 시장의 성장을 지원하는 주요 요인은 자금, 보조금, 계약 및 기타 자금 지원 제도의 형태로 정부 이니셔티브가 기업 및 다양한 연구 기관의 연구 개발 활동의 성장으로 이어진 것입니다. 따라서 이 이벤트는 예측 기간 2016-2022년 동안 응용률을 높일 것으로 예상되는 새로운 생물보존존 서비스의 발전을 이끌 것으로 예상됩니다. 생물 보존의 응용 분야의 정기적인 증가는 전체 생물 보존 존 시장의 성장에 기여하는 주요 요인 중 하나입니다. 북미는 생물 의학 연구의 신약 개발 및 치료법 도입, 급성 및 만성 질환의 진단 및 치료가 필요한 인구 증가로 인해 가장 큰 생물 보존 존 시장으로 관찰되었습니다.

시장 개요
바이오프리저베이션 제품별 시장, 2021-2031
바이오프리저베이션 용도별 시장, 2021-2031
바이오프리저베이션 세포 제공별 시장, 2021-2031
바이오프리저베이션 지역별 시장, 2021-2031
- 영국 및 유럽연합
  - 영국
  - 독일
  - 스페인
  - 이탈리아
  - 프랑스
  - 기타 유럽

제10장 아시아태평양바이오프리저베이션 시장, 2021-2031

시장 개요
바이오프리저베이션 제품별 시장, 2021-2031
바이오프리저베이션 용도별 시장, 2021-2031
바이오프리저베이션 세포 제공별 시장, 2021-2031
바이오프리저베이션 지역별 시장, 2021-2031
- 아시아태평양
  - 중국
  - 일본
  - 인도
  - 호주
  - 한국
  - 기타 아시아태평양

제11장 라텐아메리카바이오프리저베이션 시장, 2021-2031

시장 개요
바이오프리저베이션 제품별 시장, 2021-2031
바이오프리저베이션 용도별 시장, 2021-2031
바이오프리저베이션 세포 제공별 시장, 2021-2031
바이오프리저베이션 지역별 시장, 2021-2031
- 라틴아메리카
  - 브라질
  - 멕시코
  - 기타 라틴아메리카

제12장 중동 및 아프리카의의 바이오프리저베이션 시장, 2021-2031

시장 개요
바이오프리저베이션 제품별 시장, 2021-2031
바이오프리저베이션 용도별 시장, 2021-2031
바이오프리저베이션 세포 제공별 시장, 2021-2031
바이오프리저베이션 지역별 시장, 2021-2031
- 중동 및 아프리카
  - GCC
  - 아프리카
  - 기타 중동 및 아프리카

제13장 기업 개요

Azenta US Inc.
Biomatrica Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions Inc.
Taylor-Wharton.
Thermo Fisher Scientific Inc.
Panasonic Corporation
X-Therma Inc.
PrincetonCryo.
Stirling Ultracold
기타

LSH 23.06.15

Biopreservation Market is Expected to Grow at 9.5% by 2031. The process of applying natural or controlled antimicrobials to preserve food materials for extending its shelf life is known as biopreservation. The biopreservation process is usually carried out with the help of lactic acid bacteria (LAB) as they are inhibitory to microbes responsible for food spoilage. The key agents applied in biopreservation process are lactic acid bacteria, yeast, and bacteriophages. The process is carried out to preserve materials such as meat, seafood, and other food materials. The biopreservation market can be segmented as products, applications, and cell providers. The product category of biopreservation market is segmented as media, equipment, and lab information management systems. In addition equipment segment can be further sub-segmented as freezers, refrigerators, liquid nitrogen tanks and consumables; whereas, media segment is further sub-segmented as pre-formulated media and home-brew media. The key applications of biopreservation process are in biobanking, regenerative medicine, and drug discovery. The key cell providers are segmented as CD19+, tumor cells, CD34+, iPSC, MSC, and hESC.

The key factors assisting the growth of biopreservation market are government initiatives in the form of funds, grants, contracts and other funding systems have led to the growth in the research and development activities of the companies and various research organizations. Thus, this event is expected to lead the progress of new bio-preservation services which are further expected to boost application rates during the forecast period 2016 - 2022. Periodic increase in the application areas of bio-preservation is one of the key contributors towards the overall growth of the biopreservation market. North America was observed as the largest biopreservation market due to introduction of new drug developments and therapies in biomedical research and rise in the population requiring diagnosis and treatment of acute and chronic diseases in this region.

Key Players Identified for Biopreservation Market Include but are Not Limited to:

Azenta US, Inc., Biomatrica, Inc., BioLife Solutions, MVE Biological Solutions, LabVantage Solutions, Inc., Taylor-Wharton., Thermo Fisher Scientific, Inc., Panasonic Corporation, X-Therma Inc., PrincetonCryo., Stirling Ultracold And Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Biopreservation market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Biopreservation market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Segmentation

Product

Media
- Home-Brew Media
- Pre-formulated Media

Equipment
- Freezers
- Refrigerators
- Liquid Nitrogen Tanks
- Consumables
- Lab Information Management Systems

Application

Regenerative Medicine
Biobanking
Drug Discovery

Cell Providers

CD34+
CD19+
MSC
iPSC
hESC
Tumor Cells

Region Segment (2021-2031; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Biopreservation market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Biopreservation market?

Which is the largest regional market for Biopreservation market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Biopreservation market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Biopreservation market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Biopreservation Market
2.2. Global Biopreservation Market, By Product, 2022 (US$ Million)
2.3. Global Biopreservation Market, By Application, 2022 (US$ Million)
2.4. Global Biopreservation Market, By Cell Providers, 2022 (US$ Million)
2.5. Global Biopreservation Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Biopreservation Market: Competitive Analysis

3.1. Market Positioning of Key Biopreservation Market Vendors
3.2. Strategies Adopted by Biopreservation Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Biopreservation Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Biopreservation Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Biopreservation Market: By Product, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Media
  - 5.3.1.1. Home-Brew Media
  - 5.3.1.2. Pre-formulated Media
- 5.3.2. Equipment
  - 5.3.2.1. Freezers
  - 5.3.2.2. Refrigerators
  - 5.3.2.3. Liquid Nitrogen Tanks
  - 5.3.2.4. Consumables
- 5.3.3. Lab Information Management Systems

6. Biopreservation Market: By Application, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Regenerative Medicine
- 6.3.2. Biobanking
- 6.3.3. Drug Discovery

7. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. CD34+
- 7.3.2. CD19+
- 7.3.3. MSC
- 7.3.4. iPSC
- 7.3.5. hESC
- 7.3.6. Tumor Cells

8. North America Biopreservation Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
8.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
8.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
8.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

9. UK and European Union Biopreservation Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
9.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
9.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
9.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.4.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.4.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.5.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.5.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.6.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.6.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

10. Asia Pacific Biopreservation Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
10.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
10.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
10.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.4.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.4.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.5.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.5.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.6.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.6.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

11. Latin America Biopreservation Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
11.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
11.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
11.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

12. Middle East and Africa Biopreservation Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
12.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
12.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
12.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)

13. Company Profile

13.1. Azenta US, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Biomatrica, Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. BioLife Solutions
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. MVE Biological Solutions
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. LabVantage Solutions, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. Taylor-Wharton.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. Thermo Fisher Scientific, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Panasonic Corporation
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. X-Therma Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. PrincetonCryo.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Stirling Ultracold
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,500

￦ 6,511,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 10명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,500

￦ 9,404,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 9,000

￦ 13,022,000

※ 부가세 별도